Chordate Medical (Sweden) Performance
| CMH Stock | 12.55 0.25 1.95% |
The firm shows a Beta (market volatility) of 0.16, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Chordate Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Chordate Medical is expected to be smaller as well. At this point, Chordate Medical Holding has a negative expected return of -0.85%. Please make sure to confirm Chordate Medical's maximum drawdown, daily balance of power, period momentum indicator, as well as the relationship between the skewness and day typical price , to decide if Chordate Medical Holding performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Chordate Medical Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Begin Period Cash Flow | 3.6 M | |
| Free Cash Flow | -20.6 M |
Chordate |
Chordate Medical Relative Risk vs. Return Landscape
If you would invest 2,448 in Chordate Medical Holding on September 24, 2024 and sell it today you would lose (1,193) from holding Chordate Medical Holding or give up 48.73% of portfolio value over 90 days. Chordate Medical Holding is producing return of less than zero assuming 5.9448% volatility of returns over the 90 days investment horizon. Simply put, 52% of all stocks have less volatile historical return distribution than Chordate Medical, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Chordate Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chordate Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chordate Medical Holding, and traders can use it to determine the average amount a Chordate Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1435
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CMH |
Estimated Market Risk
| 5.94 actual daily | 52 52% of assets are less volatile |
Expected Return
| -0.85 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Chordate Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chordate Medical by adding Chordate Medical to a well-diversified portfolio.
Chordate Medical Fundamentals Growth
Chordate Stock prices reflect investors' perceptions of the future prospects and financial health of Chordate Medical, and Chordate Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chordate Stock performance.
| Return On Equity | -1.68 | |||
| Return On Asset | -0.71 | |||
| Operating Margin | (54.40) % | |||
| Current Valuation | 102.78 M | |||
| Shares Outstanding | 157.71 M | |||
| Price To Book | 5.80 X | |||
| Price To Sales | 3,320 X | |||
| Revenue | 618.01 K | |||
| EBITDA | (16.85 M) | |||
| Book Value Per Share | 0.12 X | |||
| Cash Flow From Operations | (17.43 M) | |||
| Earnings Per Share | (0.18) X | |||
| Total Asset | 31.22 M | |||
About Chordate Medical Performance
Assessing Chordate Medical's fundamental ratios provides investors with valuable insights into Chordate Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Chordate Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Chordate Medical Holding performance evaluation
Checking the ongoing alerts about Chordate Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chordate Medical Holding help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Chordate Medical generated a negative expected return over the last 90 days | |
| Chordate Medical has high historical volatility and very poor performance | |
| Chordate Medical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 618.01 K. Net Loss for the year was (19.76 M) with profit before overhead, payroll, taxes, and interest of 1.93 M. | |
| Chordate Medical generates negative cash flow from operations | |
| About 40.0% of the company shares are held by company insiders |
- Analyzing Chordate Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chordate Medical's stock is overvalued or undervalued compared to its peers.
- Examining Chordate Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chordate Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chordate Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chordate Medical's stock. These opinions can provide insight into Chordate Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Chordate Stock Analysis
When running Chordate Medical's price analysis, check to measure Chordate Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chordate Medical is operating at the current time. Most of Chordate Medical's value examination focuses on studying past and present price action to predict the probability of Chordate Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chordate Medical's price. Additionally, you may evaluate how the addition of Chordate Medical to your portfolios can decrease your overall portfolio volatility.